Skip to main content

GSK and CureVac join forces to develop vaccines targeting new COVID-19 variants

GSK and CureVac said their approach could potentially tackle multiple coronavirus strains in one vaccine shot
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.